Blend Labs Inc

On May 24, 2024, Oxana Tkach, our Controller, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 70,000 shares of our Class A common stock, with the exact number of shares to be sold pursuant to Ms. Tkach’s trading arrangement to be determined based on market prices of our Class A common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until March 31, 2025, subject to early termination for certain specified events set forth in the trading arrangement, or earlier if all transactions under the trading arrangement are completed.

On June 7, 2024, Winnie Ling, our Head of Legal and People, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 150,000 shares of our Class A common stock, with the exact number of shares to be sold pursuant to Mrs. Ling’s trading arrangement to be determined based on market prices of our Class A common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until February 28, 2025, subject to early termination for certain specified events set forth in the trading arrangement, or earlier if all transactions under the trading arrangement are completed.

On June 14, 2024, Nima Ghamsari, our Head of Blend, Co-Founder, and Chair of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 2,400,000 shares of our Class A common stock plus sales of shares of our Class A common stock to be issued upon the vesting of restricted stock units intended to generate an aggregate of approximately $450,000, with the exact number of shares to be sold pursuant to Mr. Ghamsari’s trading arrangement to be determined based on market prices of our Class A common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until February 10, 2025, or earlier if all transactions under the trading arrangement are completed.

No other officers or directors, as defined in Rule 16a-1(f), adopted orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408, during the last fiscal quarter.